Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OPPS Pass-Through Category Needed For Ascension’s MCP and PIP – MDMA

This article was originally published in The Gray Sheet

Executive Summary

Ascension Orthopedics' MCP and PIP total finger joint prostheses should be given a new "pass-through" category in the 2003 hospital outpatient prospective payment update, according to the Medical Device Manufacturers Association

You may also be interested in...



Multiple Procedure Discount Will Not Apply To APC 225 – OPPS Final Rule

The status indicator for APC 225 (implantation of neurostimulator electrodes) will be changed to "S" for significant procedure, preventing it from receiving a multiple procedure discount, according to the 2003 hospital outpatient prospective payment system final rule

Multiple Procedure Discount Will Not Apply To APC 225 – OPPS Final Rule

The status indicator for APC 225 (implantation of neurostimulator electrodes) will be changed to "S" for significant procedure, preventing it from receiving a multiple procedure discount, according to the 2003 hospital outpatient prospective payment system final rule

OPPS 2003 Proposed Rule Contains Payment Cuts For 80% Of Devices – Scully

Ambulatory payment classification 0107 (insertion of cardioverter-defibrillator leads) faces a 51% payment rate reduction compared with its 2002 reimbursement level, according to the hospital outpatient prospective payment system (OPPS) proposed rule for 2003

Related Content

UsernamePublicRestriction

Register

OM016193

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel